Global Lisinopril Market Insights, Forecast to 2028

Publisher Name :
Date: 11-Mar-2022
No. of pages: 129
Inquire Before Buying

Lisinopril market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lisinopril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- 2.5mg

- 5mg

- 10mg

- 20mg

- 30mg

- 40mg

Segment by Application

- Hospital

- Drug Store

By Company

- Actavis Elizabeth

- Apotex

- Aurobindo Pharma

- Ivax Pharmaceuticals

- Lek Pharmaceuticals

- Lupin

- Mylan Pharmaceuticals

- Ranbaxy Pharmaceuticals

- Novartis

- Teva Pharmaceuticals

- Vintage Pharmaceuticals

- Watson Laboratories

- West Ward Pharmaceutical

- Wockhardt

- Merck Research Laboratories

- Astrazeneca

- Alvogen

- Hikma

- Prinston

- Accord Hlthcare

- CASI Pharms

- Invagen Pharms

- SUN Pharm

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Lisinopril Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Lisinopril Product Introduction
1.2 Market by Type
1.2.1 Global Lisinopril Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Market by Application
1.3.1 Global Lisinopril Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lisinopril Sales Estimates and Forecasts 2017-2028
2.2 Global Lisinopril Revenue Estimates and Forecasts 2017-2028
2.3 Global Lisinopril Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lisinopril Sales by Region
2.4.1 Global Lisinopril Sales by Region (2017-2022)
2.4.2 Global Sales Lisinopril by Region (2023-2028)
2.5 Global Lisinopril Revenue by Region
2.5.1 Global Lisinopril Revenue by Region (2017-2022)
2.5.2 Global Lisinopril Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lisinopril Sales by Manufacturers
3.1.1 Global Top Lisinopril Manufacturers by Sales (2017-2022)
3.1.2 Global Lisinopril Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lisinopril in 2021
3.2 Global Lisinopril Revenue by Manufacturers
3.2.1 Global Lisinopril Revenue by Manufacturers (2017-2022)
3.2.2 Global Lisinopril Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lisinopril Revenue in 2021
3.3 Global Lisinopril Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lisinopril Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lisinopril Sales by Type
4.1.1 Global Lisinopril Historical Sales by Type (2017-2022)
4.1.2 Global Lisinopril Forecasted Sales by Type (2023-2028)
4.1.3 Global Lisinopril Sales Market Share by Type (2017-2028)
4.2 Global Lisinopril Revenue by Type
4.2.1 Global Lisinopril Historical Revenue by Type (2017-2022)
4.2.2 Global Lisinopril Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lisinopril Revenue Market Share by Type (2017-2028)
4.3 Global Lisinopril Price by Type
4.3.1 Global Lisinopril Price by Type (2017-2022)
4.3.2 Global Lisinopril Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lisinopril Sales by Application
5.1.1 Global Lisinopril Historical Sales by Application (2017-2022)
5.1.2 Global Lisinopril Forecasted Sales by Application (2023-2028)
5.1.3 Global Lisinopril Sales Market Share by Application (2017-2028)
5.2 Global Lisinopril Revenue by Application
5.2.1 Global Lisinopril Historical Revenue by Application (2017-2022)
5.2.2 Global Lisinopril Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lisinopril Revenue Market Share by Application (2017-2028)
5.3 Global Lisinopril Price by Application
5.3.1 Global Lisinopril Price by Application (2017-2022)
5.3.2 Global Lisinopril Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lisinopril Market Size by Type
6.1.1 North America Lisinopril Sales by Type (2017-2028)
6.1.2 North America Lisinopril Revenue by Type (2017-2028)
6.2 North America Lisinopril Market Size by Application
6.2.1 North America Lisinopril Sales by Application (2017-2028)
6.2.2 North America Lisinopril Revenue by Application (2017-2028)
6.3 North America Lisinopril Market Size by Country
6.3.1 North America Lisinopril Sales by Country (2017-2028)
6.3.2 North America Lisinopril Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Lisinopril Market Size by Type
7.1.1 Europe Lisinopril Sales by Type (2017-2028)
7.1.2 Europe Lisinopril Revenue by Type (2017-2028)
7.2 Europe Lisinopril Market Size by Application
7.2.1 Europe Lisinopril Sales by Application (2017-2028)
7.2.2 Europe Lisinopril Revenue by Application (2017-2028)
7.3 Europe Lisinopril Market Size by Country
7.3.1 Europe Lisinopril Sales by Country (2017-2028)
7.3.2 Europe Lisinopril Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lisinopril Market Size by Type
8.1.1 Asia Pacific Lisinopril Sales by Type (2017-2028)
8.1.2 Asia Pacific Lisinopril Revenue by Type (2017-2028)
8.2 Asia Pacific Lisinopril Market Size by Application
8.2.1 Asia Pacific Lisinopril Sales by Application (2017-2028)
8.2.2 Asia Pacific Lisinopril Revenue by Application (2017-2028)
8.3 Asia Pacific Lisinopril Market Size by Region
8.3.1 Asia Pacific Lisinopril Sales by Region (2017-2028)
8.3.2 Asia Pacific Lisinopril Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Lisinopril Market Size by Type
9.1.1 Latin America Lisinopril Sales by Type (2017-2028)
9.1.2 Latin America Lisinopril Revenue by Type (2017-2028)
9.2 Latin America Lisinopril Market Size by Application
9.2.1 Latin America Lisinopril Sales by Application (2017-2028)
9.2.2 Latin America Lisinopril Revenue by Application (2017-2028)
9.3 Latin America Lisinopril Market Size by Country
9.3.1 Latin America Lisinopril Sales by Country (2017-2028)
9.3.2 Latin America Lisinopril Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lisinopril Market Size by Type
10.1.1 Middle East and Africa Lisinopril Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lisinopril Revenue by Type (2017-2028)
10.2 Middle East and Africa Lisinopril Market Size by Application
10.2.1 Middle East and Africa Lisinopril Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lisinopril Revenue by Application (2017-2028)
10.3 Middle East and Africa Lisinopril Market Size by Country
10.3.1 Middle East and Africa Lisinopril Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lisinopril Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Actavis Elizabeth
11.1.1 Actavis Elizabeth Corporation Information
11.1.2 Actavis Elizabeth Overview
11.1.3 Actavis Elizabeth Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Actavis Elizabeth Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Actavis Elizabeth Recent Developments
11.2 Apotex
11.2.1 Apotex Corporation Information
11.2.2 Apotex Overview
11.2.3 Apotex Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Apotex Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Apotex Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Corporation Information
11.3.2 Aurobindo Pharma Overview
11.3.3 Aurobindo Pharma Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Aurobindo Pharma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aurobindo Pharma Recent Developments
11.4 Ivax Pharmaceuticals
11.4.1 Ivax Pharmaceuticals Corporation Information
11.4.2 Ivax Pharmaceuticals Overview
11.4.3 Ivax Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ivax Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ivax Pharmaceuticals Recent Developments
11.5 Lek Pharmaceuticals
11.5.1 Lek Pharmaceuticals Corporation Information
11.5.2 Lek Pharmaceuticals Overview
11.5.3 Lek Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lek Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lek Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Corporation Information
11.6.2 Lupin Overview
11.6.3 Lupin Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lupin Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Mylan Pharmaceuticals
11.7.1 Mylan Pharmaceuticals Corporation Information
11.7.2 Mylan Pharmaceuticals Overview
11.7.3 Mylan Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mylan Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Pharmaceuticals Recent Developments
11.8 Ranbaxy Pharmaceuticals
11.8.1 Ranbaxy Pharmaceuticals Corporation Information
11.8.2 Ranbaxy Pharmaceuticals Overview
11.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ranbaxy Pharmaceuticals Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Teva Pharmaceuticals
11.10.1 Teva Pharmaceuticals Corporation Information
11.10.2 Teva Pharmaceuticals Overview
11.10.3 Teva Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceuticals Recent Developments
11.11 Vintage Pharmaceuticals
11.11.1 Vintage Pharmaceuticals Corporation Information
11.11.2 Vintage Pharmaceuticals Overview
11.11.3 Vintage Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Vintage Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Vintage Pharmaceuticals Recent Developments
11.12 Watson Laboratories
11.12.1 Watson Laboratories Corporation Information
11.12.2 Watson Laboratories Overview
11.12.3 Watson Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Watson Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Watson Laboratories Recent Developments
11.13 West Ward Pharmaceutical
11.13.1 West Ward Pharmaceutical Corporation Information
11.13.2 West Ward Pharmaceutical Overview
11.13.3 West Ward Pharmaceutical Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 West Ward Pharmaceutical Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 West Ward Pharmaceutical Recent Developments
11.14 Wockhardt
11.14.1 Wockhardt Corporation Information
11.14.2 Wockhardt Overview
11.14.3 Wockhardt Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Wockhardt Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Wockhardt Recent Developments
11.15 Merck Research Laboratories
11.15.1 Merck Research Laboratories Corporation Information
11.15.2 Merck Research Laboratories Overview
11.15.3 Merck Research Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Merck Research Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Merck Research Laboratories Recent Developments
11.16 Astrazeneca
11.16.1 Astrazeneca Corporation Information
11.16.2 Astrazeneca Overview
11.16.3 Astrazeneca Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Astrazeneca Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Astrazeneca Recent Developments
11.17 Alvogen
11.17.1 Alvogen Corporation Information
11.17.2 Alvogen Overview
11.17.3 Alvogen Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Alvogen Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Alvogen Recent Developments
11.18 Hikma
11.18.1 Hikma Corporation Information
11.18.2 Hikma Overview
11.18.3 Hikma Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Hikma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hikma Recent Developments
11.19 Prinston
11.19.1 Prinston Corporation Information
11.19.2 Prinston Overview
11.19.3 Prinston Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Prinston Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Prinston Recent Developments
11.20 Accord Hlthcare
11.20.1 Accord Hlthcare Corporation Information
11.20.2 Accord Hlthcare Overview
11.20.3 Accord Hlthcare Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Accord Hlthcare Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Accord Hlthcare Recent Developments
11.21 CASI Pharms
11.21.1 CASI Pharms Corporation Information
11.21.2 CASI Pharms Overview
11.21.3 CASI Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 CASI Pharms Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 CASI Pharms Recent Developments
11.22 Invagen Pharms
11.22.1 Invagen Pharms Corporation Information
11.22.2 Invagen Pharms Overview
11.22.3 Invagen Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Invagen Pharms Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Invagen Pharms Recent Developments
11.23 SUN Pharm
11.23.1 SUN Pharm Corporation Information
11.23.2 SUN Pharm Overview
11.23.3 SUN Pharm Lisinopril Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 SUN Pharm Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 SUN Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lisinopril Industry Chain Analysis
12.2 Lisinopril Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lisinopril Production Mode & Process
12.4 Lisinopril Sales and Marketing
12.4.1 Lisinopril Sales Channels
12.4.2 Lisinopril Distributors
12.5 Lisinopril Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lisinopril Industry Trends
13.2 Lisinopril Market Drivers
13.3 Lisinopril Market Challenges
13.4 Lisinopril Market Restraints
14 Key Findings in The Global Lisinopril Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Lisinopril Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 2.5mg
Table 3. Major Manufacturers of 5mg
Table 4. Major Manufacturers of 10mg
Table 5. Major Manufacturers of 20mg
Table 6. Major Manufacturers of 30mg
Table 7. Major Manufacturers of 40mg
Table 8. Global Lisinopril Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Lisinopril Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Lisinopril Sales by Region (2017-2022) & (K Units)
Table 11. Global Lisinopril Sales Market Share by Region (2017-2022)
Table 12. Global Lisinopril Sales by Region (2023-2028) & (K Units)
Table 13. Global Lisinopril Sales Market Share by Region (2023-2028)
Table 14. Global Lisinopril Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Lisinopril Revenue Market Share by Region (2017-2022)
Table 16. Global Lisinopril Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Lisinopril Revenue Market Share by Region (2023-2028)
Table 18. Global Lisinopril Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Lisinopril Sales Share by Manufacturers (2017-2022)
Table 20. Global Lisinopril Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Lisinopril Revenue Share by Manufacturers (2017-2022)
Table 22. Lisinopril Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Lisinopril by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2021)
Table 25. Lisinopril Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Lisinopril Product Offered
Table 27. Date of Manufacturers Enter into Lisinopril Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Lisinopril Sales by Type (2017-2022) & (K Units)
Table 30. Global Lisinopril Sales by Type (2023-2028) & (K Units)
Table 31. Global Lisinopril Sales Share by Type (2017-2022)
Table 32. Global Lisinopril Sales Share by Type (2023-2028)
Table 33. Global Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Lisinopril Revenue Share by Type (2017-2022)
Table 36. Global Lisinopril Revenue Share by Type (2023-2028)
Table 37. Lisinopril Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Lisinopril Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Lisinopril Sales by Application (2017-2022) & (K Units)
Table 40. Global Lisinopril Sales by Application (2023-2028) & (K Units)
Table 41. Global Lisinopril Sales Share by Application (2017-2022)
Table 42. Global Lisinopril Sales Share by Application (2023-2028)
Table 43. Global Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Lisinopril Revenue Share by Application (2017-2022)
Table 46. Global Lisinopril Revenue Share by Application (2023-2028)
Table 47. Lisinopril Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Lisinopril Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Lisinopril Sales by Type (2017-2022) & (K Units)
Table 50. North America Lisinopril Sales by Type (2023-2028) & (K Units)
Table 51. North America Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Lisinopril Sales by Application (2017-2022) & (K Units)
Table 54. North America Lisinopril Sales by Application (2023-2028) & (K Units)
Table 55. North America Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Lisinopril Sales by Country (2017-2022) & (K Units)
Table 58. North America Lisinopril Sales by Country (2023-2028) & (K Units)
Table 59. North America Lisinopril Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Lisinopril Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Lisinopril Sales by Type (2017-2022) & (K Units)
Table 62. Europe Lisinopril Sales by Type (2023-2028) & (K Units)
Table 63. Europe Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Lisinopril Sales by Application (2017-2022) & (K Units)
Table 66. Europe Lisinopril Sales by Application (2023-2028) & (K Units)
Table 67. Europe Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Lisinopril Sales by Country (2017-2022) & (K Units)
Table 70. Europe Lisinopril Sales by Country (2023-2028) & (K Units)
Table 71. Europe Lisinopril Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Lisinopril Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Lisinopril Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Lisinopril Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Lisinopril Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Lisinopril Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Lisinopril Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Lisinopril Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Lisinopril Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Lisinopril Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Lisinopril Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Lisinopril Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Lisinopril Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Lisinopril Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Lisinopril Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Lisinopril Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Lisinopril Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Lisinopril Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Lisinopril Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Lisinopril Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Lisinopril Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Lisinopril Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Lisinopril Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Lisinopril Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Lisinopril Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Lisinopril Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Lisinopril Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Lisinopril Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Lisinopril Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Lisinopril Revenue by Country (2023-2028) & (US$ Million)
Table 109. Actavis Elizabeth Corporation Information
Table 110. Actavis Elizabeth Description and Major Businesses
Table 111. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Actavis Elizabeth Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Actavis Elizabeth Recent Developments
Table 114. Apotex Corporation Information
Table 115. Apotex Description and Major Businesses
Table 116. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Apotex Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Apotex Recent Developments
Table 119. Aurobindo Pharma Corporation Information
Table 120. Aurobindo Pharma Description and Major Businesses
Table 121. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Aurobindo Pharma Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Aurobindo Pharma Recent Developments
Table 124. Ivax Pharmaceuticals Corporation Information
Table 125. Ivax Pharmaceuticals Description and Major Businesses
Table 126. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Ivax Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Ivax Pharmaceuticals Recent Developments
Table 129. Lek Pharmaceuticals Corporation Information
Table 130. Lek Pharmaceuticals Description and Major Businesses
Table 131. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Lek Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Lek Pharmaceuticals Recent Developments
Table 134. Lupin Corporation Information
Table 135. Lupin Description and Major Businesses
Table 136. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Lupin Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Lupin Recent Developments
Table 139. Mylan Pharmaceuticals Corporation Information
Table 140. Mylan Pharmaceuticals Description and Major Businesses
Table 141. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Mylan Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Mylan Pharmaceuticals Recent Developments
Table 144. Ranbaxy Pharmaceuticals Corporation Information
Table 145. Ranbaxy Pharmaceuticals Description and Major Businesses
Table 146. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Ranbaxy Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Ranbaxy Pharmaceuticals Recent Developments
Table 149. Novartis Corporation Information
Table 150. Novartis Description and Major Businesses
Table 151. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Novartis Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Novartis Recent Developments
Table 154. Teva Pharmaceuticals Corporation Information
Table 155. Teva Pharmaceuticals Description and Major Businesses
Table 156. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Teva Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Teva Pharmaceuticals Recent Developments
Table 159. Vintage Pharmaceuticals Corporation Information
Table 160. Vintage Pharmaceuticals Description and Major Businesses
Table 161. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Vintage Pharmaceuticals Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Vintage Pharmaceuticals Recent Developments
Table 164. Watson Laboratories Corporation Information
Table 165. Watson Laboratories Description and Major Businesses
Table 166. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Watson Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Watson Laboratories Recent Developments
Table 169. West Ward Pharmaceutical Corporation Information
Table 170. West Ward Pharmaceutical Description and Major Businesses
Table 171. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. West Ward Pharmaceutical Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. West Ward Pharmaceutical Recent Developments
Table 174. Wockhardt Corporation Information
Table 175. Wockhardt Description and Major Businesses
Table 176. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 177. Wockhardt Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Wockhardt Recent Developments
Table 179. Merck Research Laboratories Corporation Information
Table 180. Merck Research Laboratories Description and Major Businesses
Table 181. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 182. Merck Research Laboratories Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Merck Research Laboratories Recent Developments
Table 184. Astrazeneca Corporation Information
Table 185. Astrazeneca Description and Major Businesses
Table 186. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 187. Astrazeneca Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Astrazeneca Recent Developments
Table 189. Alvogen Corporation Information
Table 190. Alvogen Description and Major Businesses
Table 191. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 192. Alvogen Lisinopril Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Alvogen Recent Developments
Table 194. Hikma Corporation Information
Table 195. Hikma Description and Major Businesses
Table 196. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 197. Hikma Lisinopril Product Model Numb
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs